Skip to main content
ICLR logo
ICLR
(NASDAQ)
ICON Public Limited Company
$113.55-- (--)
Loading... - Market loading

ICON Public Limited Company (ICLR) Stock Price & Financial Analysis

ICON Public Limited Company Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$108.89 - $118.05
52-Week High$211.00
52-Week Low$66.57
Open$112.00
Volume859.06K
Average Volume (3M)1.24M
Market Cap9.09B
Shares Outstanding78.08M
P/E Ratio (TTM)15.16
Forward P/E18.99
Price to Sales (P/S)1.12
Price to Book (P/B)0.97
EV/EBITDA10.20
Revenue (TTM)8.10B
Net Income (TTM)599.48M
Free Cash Flow (TTM)982.17M
EPS (TTM)$7.48
Profit Margin7.40%
Operating Margin13.99%
Return on Equity (ROE)6.42%
Debt to Equity0.37
50-Day MA$109.30
200-Day MA$154.76
52-Week Change-15.16%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About ICON Public Limited Company

What is the current stock price for ICLR?

As of the latest trading session, ICLR stock trades at $115.09. The 52-week range is $66.57–$211.00, with a day range of $108.89–$118.05.

What is the P/E ratio for ICLR?

ICON Public Limited Company's trailing P/E ratio is 15.2, meaning investors pay $15.2 for every $1 of annual earnings. The forward P/E is 19.0, reflecting analyst expectations for future earnings. ICON Public Limited Company operates in the Healthcare sector.

Does ICLR pay dividends?

ICON Public Limited Company does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ICLR?

Based on 5 analysts, the consensus for ICLR is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ICLR?

ICON Public Limited Company's market capitalization is $8.99B, classifying it as a mid-cap company. ICON Public Limited Company operates in the Healthcare sector within the Diagnostics & Research industry.